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Reticuloendothelial and mesangial function in murine immune
complex glomerulonephritis. The function of the mesangial and
reticuloendothelial system was evaluated in normal mice and in
mice with nephritis induced by lymphocytic choriomeningitis
(LCM) virus infection. Heat-aggregated human immunoglobulin
(AIgG) and colloidal carbon served as traceable materials which
could be detected in animals' blood and tissues. LCM virus-in-
fected proteinuric (LCM-P) mice, as compared to normal mice or
LCM-infected nonproteinuric (LCM) mice, had greater accumu-
lation of AIgG in their glomeruli at all times of examination fol-
lowing i.p. injection of AIgG. The removal rate of AIgG from the
kidney, however, was the same in normal and LCM-P mice, in-
dicating an unimpaired mesangial clearing system. This sug-
gested that other mechanisms were responsible for the increased
glomerular accumulation of AIgG in LCM-P mice. Reticuloendo-
thelial function was examined directly by iv. injection of AIgG
or colloidal carbon. The data demonstrate that in this model of
immune complex glomerulonephritis, colloidal material tested
was removed from the blood at a slower rate than it was in nor-
mal mice. Deficient clearance of endogenous blood-borne im-
mune complex-like material may be one of the factors playing a
role in the accumulation of immune complex-like material in the
glomeruli of these nephritic animals.
Fonction réticuloendothéliale et mesangiale dans Ia glomerulon-
éphrite murine des complexes immuns. La fonction mésangiale et
réticuloendothéliale a été évaluée chez Ia souris normale et Ia
souris atteinte de néphrite induite par l'infection au moyen du
virus de la choriomeningite lymphocytaire. L'immunoglobuline
humaine agrégde par Ia chaleur (AlgO) et le carbone colloidal
ont été utilisés comme matériaux traceurs qui peuvent être dé-
tectds dans Ic sang et les tissus des animaux. Les souris pro-
téinuriques infectées (LCM-P) par le virus LCM ont, par com-
paraison avec les souris normales ou les souris infectées non pro-
téinuriques, une plus grande accumulation d'AIgG dans leurs
glomerules a tous les délais d'examen après l'injection i.p.
dAIgG. Cependant Ia vitesse de disparition de FAIgG du rein est
Ia même chez les souris normales et LCM-P, ce qui indique un
système mesangial non altéré. Cela suggère que d'autres méca-
nismes sont responsables de l'augmentation de l'accumulation
glomérulaire d'AIgG chez les souris LCM-P. La fonction réticu-
loendothéliale a été étudiée directement par l'injection iv.
d'AIgG ou de carbone colloidal. Les résultats montrent que dans
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cc modèle de glomerulonephrite des complexes immuns l'agent
étudié a été soustrait du sang a une vitesse moindre que la nor-
male. Une clearance déficitaire du materiel semblable a du com-
plexe immun endogene pent être l'un des facteurs qui participent
a l'accumulation de matérial semblable a du complexe immun
dans les glomerules de ces animaux nephritiques.
Observations using the rabbit model of serum
sickness nephritis led investigators to the hypothe-
sis that immune complex glomerulonephritis
(ICGN) is a hypersensitivity state [1—31. Noting the
apparent similarities in pathogenesis of human and
experimental animal nephritis [4, 5], other investi-
gators have used immunosuppressive therapy for
human glomerulonephritis; the results of these trials
have been inconsistent [6].
The immune system generally does not eliminate
effectively the known etiologic agents of human
chronic ICGN, such as infectious endocarditis orga-
nisms [7], treponema pallidum infection [8], malaria
malariae [9], type B hepatitis virus [101, and various
malignant tumors [11-13]. So, ICGN may be con-
sidered as an immunodeficiency state, determined
by the host's inability to eliminate the specific agent
inducing immune complex glomerulonephritis. This
concept is illustrated well in mice chronically infect-
ed with lymphocytic choriomeningitis virus (LCM);
these mice are immunologically tolerant to the virus
[14, 151. We have found that although glomerular
immune complex accumulation does occur, the im-
munoglobulin eluted from renal tissue has no bind-
ing specificity for viral antigens [16]. Our result dif-
fers from that found by the only other group which
has studied [17] this important point.
Since our data indicated that hypersensitivity
does not explain the glomerular immune complex
disease in this model, we investigated the glomeru-
lar mesangial function and systemic reticuloendo-
thelial function. In 1933, Zimmerman [18] first de-
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scribed the intercapillary space in the centrolobular
region of the renal glomerulus. He named this re-
gion the mesangium. Subsequent reports have dem-
onstrated that circulating immune complexes, ag-
gregated protein, and other microparticulate col-
loidal material may enter the mesangium and be
phagocytized by mesangial cells [19—221. That ab-
normalities in the glomerular mesangium may be in-
volved in pathologic processes was demonstrated
first by Latta [23], who found mesangial electron-
dense deposits in a variety of glomerular diseases.
On the other hand, clearance of particulate material
from the blood is primarily dependent on the phago-
cytic capacity of the reticuloendothelial system
(RES) [24, 25]. Conceptually, accumulation of for-
eign material within the mesangial space might oc-
cur secondary to a decreased intrinsic clearing ca-
pacity of the mesangial system or to an overload of
the system with excessive quantities of blood-borne
foreign material not removed by the RES [26]. Our
studies described here use the LCM model of ICGN
to determine whether mesangial accumulation of
immune complexes is secondary to defective mesan-
gial clearance or to inadequate systemic retic-
uloendothelial clearance of colloid from the blood,
leading to mesangial overload.
Methods
SWRIJ mice were bred in our laboratories from
stock originally obtained from Jackson Laboratory
(Bar Harbor, Maine). A chronic ICGN was induced
by administration of LCM to neonatal mice. These
mice were injected intracerebrally with LD50 (10I
0.03 ml of tissue culture supernatant) from a mouse
embryo fibroblast culture infected with LCM virus
(NIH strain CA 1371) [15]. Animals were weaned at
1 month of age and used for experiments at 3 to 5
months of age. Aged-matched normal uninfected
mice were obtained from the breeding stock used to
produce virus-infected mice. In this study, "normal
mice" refers to SWR/J mice which are not protein-
uric and not infected with LCM virus, "LCM
mice" refers to SWRIJ mice chronically infected
with LCM virus since birth, and LCM-P mice" re-
fers to LCM mice which have developed abnormal
albuminuria.
Collection of urine and quantification of albumin-
uria. The method of urine collection for quan-
tification of albuminuria in mice has been described
previously [27]. Abnormal albuminuria was de-
fined, based on our previous results [27], as more
than 0.4 mg of urinary albumin excreted per 18
hours.
Preparation of immune complex-like material.
Heat-aggregated human gamma globulin (AIgG)
was selected, based on the studies of others [22, 28,
29], as an immune complex-like material which
could be quantified in regard to mesangial accumu-
lation and RES function. The heat-aggregated human
gamma globulin was prepared according to the
method of Mauer et at [29] with minor modifica-
tions. We iodinated 250 mg of human gamma globu-
lin (Immu-G, Parke-Davis) with 5 mCi of iodine 125
according to the method of McConahey and Dixon
[30], and we fluoresceinated 4.5 g of human gamma
globulin (pH, 8.6) with 25mg of fluorescein isothio-
cyanate (final volume, 120 ml) at 40 C overnight.
Free fluorescein was removed by dialysis against
phosphate buffered saline (PBS; 5 m phosphate;
pH, 7.4); the molar fluorescein to protein ratio aver-
aged 2.3: 1. The human gamma globulin fractions la-
beled with radioactive iodine or fluorescein were
combined and heat-aggregated for 15 mm at 63° C
as described by Mauer et al [29]. After resuspension
of the aggregated protein, insoluble particulate mat-
ter was removed by centrifugation at x 12,000g for
10 mm in a Sorvall refrigerated centrifuge, and the
protein concentration was determined by the meth-
od of Lowry [31]. The product was stored frozen at
7Ø0 C. Prior to use, it was thawed and centrifuged
for 10 mm at x l2,000g to remove insoluble aggre-
gates.
Sucrose density gradient and gel filtration chro-
matography. Zonal centrifugation with preformed
linear sucrose density gradients (20 to 60%) was
used to characterize the AIgG. Linearity of the gra-
dients was confirmed by refractometry. Centrifuga-
tion was performed in an ultracentrifuge (Beckman
Spinco model L6-65) at 40 C for 14 hours at 25,000
rpm with either a Beckman SW27 rotor (x82,800g)
or an SW4O rotor (x78,900g). Following needle
puncture of the bottom of the tubes, fractions were
collected with a Gilson automatic fraction collector.
The 12I-labeled fractions were counted in a gamma
scintillation spectrophotometer (Packard, model
578).
Gel filtration chromatography with agarose beads
(Biogel A, Biorad Laboratories, Richmond, Calif.)
was used to fractionate the AIgG based upon mo-
lecular size. The column was initially equilibrated
with PBS containing 1.6 g of human gamma globulin
per liter to prevent nonspecific adherence of the
AIgG to the agarose beads. Fractions were collect-
ed automatically and counted in a gamma scintilla-
tion spectrophotometer.
Method of quantification of renal accumulation
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Fig. 1. Biogel A-150 column chromatography of '2'I-labeled heat-aggregated human gamma globulin. Selected fractions were sized
using various pore size Biogel A columns, and the estimated molecular weights of the collected fractions were: (A) greater than
150 million daltons;(B) 50 million to 150 million daltons;(C) 5 million to 50 million daltons;(D) 1.5 million to 5 million daltons;(E) 160,000
to 1.5 million daltons; (F) less than 160,000 daltons. Of the radioactivity originally applied to the column, 93% was recovered in the
fractions.
of AIgG. Renal accumulation refers to the net
amount of AIgG adherent to renal tissue at any
point in time. Although not directly measured in the
following experiments, "renal uptake" refers to
AIgG entering renal tissue. "Renal clearance" re-
fers to the removal from the kidney of previously
accumulated AIgG. For reasons presented sub-
sequently, we think renal accumulation and clear-
ance occur predominantly, although not exclusive-
ly, in the glomerular mesangium.
Preliminary immunofluorescent microscopic
studies demonstrated that less than 0.8 mg of AIgG
per gram of body weight resulted in little demon-
strable glomerular localization of the injected mate-
rial. Mice to be evaluated received an i.p. injection
of 1 mg of AIgG per gram of body weight. No pre-
medication was used, and there was no mortality or
apparent ill effect. At various times after injection,
the animals were etherized and exsanguinated by
severance of the axillary vessels. Blood was collect-
ed for the measurement of protein-bound radio-
active iodine, mouse immunoglobulin, mouse third
component of complement (C3), mouse albumin,
and hematocrit. The skin was stripped from the ani-
mal's abdomen and 1 ml PBS was injected perito-
neally and rinsed about the peritoneal cavity; 0.5 ml
of the contents of the peritoneal cavity was aspi-
rated for the determination of the quantity of 'I
present. Assuming I ml of fluid to be present in the
peritoneal cavity, we could calculate a minimum re-
sidual quantity of aggregates for comparison to the
amount previously injected. Following this proce-
dure, we removed the left kidney, lightly blotted it,
and sealed it in a short segment of 3/s-inch dialysis
tubing. Specimens of the right kidney, liver, pan-
creas, spleen, gonad, lung, heart, thymus, and brain
were fixed in Bouin's solution for examination by
light microscopy. Specimens of the liver, kidney,
brain, and spleen were frozen in liquid nitrogen for
subsequent examination by immunofluorescent mi-
croscopy.
The total quantity of I in the left kidney was
determined (Packard Auto-Gamma Scintillation
Spectrophotometer). The kidney sealed in dialysis
tubing was mashed between the fingers of a gloved
hand and then dialyzed to remove nonprotein-
bound radioactivity. It was found that this required
only overnight dialysis. The amount of radioactiv-
ity in the tissue sediment after centrifugation at
X2,000g for 10 mm was used as a measure of tissue-
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Fig. 2. Sucrose density gradient pattern ofaggregates from the blood of normal S WRIJ mice injected i.v. with AIgG and bled 2, 5, 8, and
11 mm later. Broken line represents AIgG starting material. Gradients were centrifuged in a Beckman SW4O Rotor at 25,000 rpm for 14
hours.
bound AIgG. The addition of free 125J or 1251-IgG to
tissue homogenates, which were subsequently dia-
lyzed and centrifuged, resulted in less than 5% of
the added radioactivity binding to the tissue. Serum
concentrations of AIgG were determined by mea-
suring trichloroacetic acid (TCA) precipitable radio-
activity.
Immunofluorescent studies, pathologic examina-
tion, and autoradiography. Tissue fixed in Bouin's
solution was sectioned and stained with hematoxy-
lin and eosin or periodic-acid-Schiff (PAS) reaction
for examination by light microscopy. Frozen sec-
tions examined by immunofluorescent microscopy
had easily seen patterns of green fluorescence, visu-
alized with an FITC excitor filter and a BG-12 bar-
rier filter with an Olympus immunofluorescent mi-
croscope with phiom illumination. Rhodamine-con-
jugated antisera to mouse immunoglobulin and
mouse C3 (Cappel Laboratories, Downington, Pa.)
were used to determine the location of endogenous
mouse immune complexes. Visualization of the
rhodamine fluorescence was done with IF-545 and
BG-36 excitor filters and a 0-590 barrier filter. There
was virtually no visual contamination of the rhoda-
mine system by fluorescein, although a subdued or-
ange fluorescence from rhodamine was sometimes
visible when examining tissues with the fluorescein
detection system.
It is acknowledged that the use of immuno-
fluorescent microscopy for quantification of gb-
merular immune accumulations is subjective. The
technique, however, has been included for com-
parison to the results of 125J localization in kidneys.
Sections were graded without knowledge of the
type of animal being examined or the length of time
after AIgG injection. The grading system used was:
negative, no observed fluorescence; trace (numeri-
cal grade of 1/2), small scattered mesangial fluores-
cence; 1+, large scattered nonconfluent mesangial
fluorescence; 2+, confluent mesangial fluores-
cence; 3+, extension of fluorescence into capillary
loops; 4+, large expanded confluent mesangial fluo-
rescence with extension into capillary loops. When
given sections had marked variation in grades for
individual glomeruli, the number of glomeruli with
each grade (total glomeruli counted > 20) were av-
eraged to obtain a grade for the whole section.
Standard autoradiographic techniques as de-
scribed by Rogers [32] were used. Gelatin-coated
frozen sections of renal tissue from mice injected
Sucrose gradient, wt %
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Fig. 3. Sucrose density gradient pa/tern of blood from normal SWRIJ mice injected i.p. with AIgG and bled at 1, 2, 4, 8, and 24 hours.
Broken line represents aggregated IgG starting material. Gradients were centrifuged in an SW-27 Rotor at 25,000 rpm for 14 hours.
with AIgG were emersed in Kodak NTB-2 liquid
photographic emulsion at 43° C and exposed for 3
weeks in silica-gel-dessicated container at 4° C. The
sections were developed (Kodak D- 19 developer)
and fixed (Kodak Rapid Fixer, Eastman Kodak
Co., Rochester, N.Y.). Following development,
sections were examined by light microscopy for sil-
ver grain deposition and immunofluorescent mi-
croscopy for fluorescein deposition.
Measurement of the phagocytic function of the
reticuloendothelial system. RES clearance of
blood-borne material was evaluated using colloidal
carbon (Pelikan Carbon, Cl1/l43a, Gunther Wag-
ner, Hanover, Germany) or AIgG by the method of
Biozzi et al [24, 25j. Colloidal carbon (4 mg125 g
body wt) was injected into a tail vein of each mouse,
and 20 itl of blood were obtained from the retro-
orbital plexus at 2, 5, 9, and 12 mm after injection.
The blood samples were added to 3 ml of distilled
water and vigorously mixed, after which the optical
density was measured in a Coleman spectropho-
tometer at 650 mis. Using a standard curve, the car-
bon concentration of each blood sample was deter-
mined. The phagocytic index (k) [24, 25] and the t½
of carbon disappearance rates were calculated by
means of a regression line derived from the log
transformation of carbon concentration values with
the following equation: log C = kt, where k is the
slope of the relationship between the logarithm of
the blood colloidal carbon concentration (log C) and
time in minutes (t).
The second group of mice received an i.v. injec-
tion of 4 mg of AIgG per 25 g body wt, and blood
samples were obtained from the retroorbital plexus
at 2, 5, 8, and II mm. Each blood sample was added
to 0.5 ml of fetal calf serum, and 0.5 ml of 10% TCA
was added to precipitate protein-bound iodine. The
sample was centrifuged for 30 mm at x 2 ,000g, the
supernatant was removed, and protein bound 125J
counts per minute were determined (Packard Auto-
Gamma Scintillation Spectrophotometer). The
phagocytic index and the P12 of serum aggregate dis-
appearance was determined by means of a regres-
sion line as above. Statistical significance was de-
termined using unpaired Student's t test [33].
Results
Characterization of aggregated gamma globulin.
It has been shown that a linear relationship exists
between the log10 molecular weight of globular pro-
teins and the rate at which the protein migrates on
gel filtration [34]. A sample of AIgG was applied to
a Biogel A-l50 column with subsequent recovery of
93% of the applied radioactivity. Following the frac-
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Fig. 4. Glomerular deposition offluorescein-labeled heat-aggregated human gamma globulin. The tissue is from an albuminuric LCM
infected mouse 24 hours after the i.p. injection of 25 mg of heat-aggregated human gamma globulin. The intrinsic fluorescence of the
fluorescein-labeled heat-aggregated human gamma globulin is present only in the glomeruli (original magnification, X200).
tionation of the AIgG, the above relationship was
used to estimate the size of the AIgG in selected
fractions. Samples estimated to contain AIgG of
molecular weights greater than 1.5 million, 5 mil-
lion, 50 million, and 150 million daltons were ap-
plied to Biogel A columns containing Biogel A-l.5,
A-5, A-50, and A-iSO, respectively. Fraction 44
(Fig. I) was estimated to have a molecular weight of
1.5 million daltons or greater and was completely
excluded from a Biogel A-l.5 column. Fraction 35
(Fig. 1) was estimated to be greater than 5 million
daltons and was completely excluded by Biogel A-5
column. Fraction 25 was estimated to be greater
than 50 million daltons (Fig. 1), but 35% was not
contained in the void volume. Fraction 15 was esti-
mated to be approximately 150 million daltons, al-
though 40% was not contained in the void volume.
Fractions 56, 57, 58 (Fig. 1) were the final portion of
the elution volume from the column and contained
unaggregated human gamma globulin. A blood
sample obtained from a mouse 2 mm after i.v. injec-
tion of AIgG was not altered in regard to the distri-
bution of molecular sizes (Fig. 1) determined by the
same technique with Biogel A-ISO. Thus, the full
spectrum of molecular weights of injected AIgG cir-
culates without mechanically occluding capillaries.
The relative size of AIgG obtained from the blood
of injected mice was examined with sucrose density
gradients. Figure 2 shows the results of five sucrose
gradients, comparing the starting material to AJgG
in blood samples of four normal SWR/J mice ex-
sanguinated 2, 5, 8, and 11 mm after i.v. injection of
4 mg of AIgG. The AIgG sedimentation pattern is
not altered during the period of observation. Like-
wise, the sedimentation pattern of AIgG in blood
samples from mice injected i.p. with 25 mg of AIgG
resembled the starting material until at least 4 hours
after injection (Fig. 3). Eight hours after injection,
the relative size of the AIgG remaining in the blood
decreased slightly (Fig. 3), and by 24 hours most of
the AIgG had been cleared from the blood. The re-
sults depicted in Figs. 2 and 3 were obtained in nor-
mal SWR!J mice; entirely similar results were ob-
tained in LCM-infected mice.
Kinetics and metabolism of i.p. injected heat-ag-
gregated human gamma globulin. Removal of
AIgG from the peritoneal cavity of mice was re-
markably rapid, with 80% of the material absorbed
within 4 hours in either the normal or virus-infected
mice. In all mice studied, less than 5% of the inject-
ed material could be detected in the peritoneal wash
24 hours after injection, by which time more than
60% of the injected radioactivity had been excreted
in the urine, primarily (70%) as non-TCA precipi-
table counts. More than 99% of the TCA precipi-
table radioactivity in the urine was dialyzable, in-
dicating that only fragments of the aggregated hu-
man gamma globulin passed the glomerular barrier.
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Fig. 5. Autoradiograph of renal tissue from a mouse injected
with 25 mg of AIgG 24 hours prior to autopsy. Panel A shows the
silver grains from 125J localized in the renal tissue. The added
outlines were drawn with the aid of a template prepared to out-
line glomeruli shown in Panel B, which is an immunofluorescent
photomicrograph of the same tissue section. Note the pre-
dominant glomerular localization of both 9 and fluorescein.
Negligible quantities of radioactivity appeared in
stool samples. The sites of metabolism of the heat-
aggregated human gamma globulin was not deter-
mined on a quantitative basis.
Renal localization of heat-aggregated human
gamma globulin. Figure 4 is an immunofluores-
cence photomicrograph of a section of renal tis-
sue from an albuminuric LCM-infected SWRIJ
mouse which had received an i.p. injection of 25 mg
of AJgG. This particular mouse was autopsied at 24
hours after injection, and the innate fluorescence of
the fluorescein-labeled AIgG is as extensive as any
seen during these studies. Of special note is the fact
that the fluorescence is localized in the glomeruli;
neither interstitial nor tubular deposits of fluores-
cein are seen. Glomerular localization of fluores-
cein was seen from 4 hours after injection through 5
days after injection when only traces of AIgG re-
mained. The injection of 1 mg/kg body wt of
deaggregated 1251-labeled fluoresceinated human
gamma globulin (1251-F-IgG) resulted in virtually no
detectable glomerular fluorescence; in addition,
when deaggregated 1251-F-IgG was used, there was
no increased localization of 125J in tissue homoge-
nates from LCM mice as compared to normal mice,
a result different from that illustrated in Fig. 6 (de-
scribed below) when AIgG was used.
The congruence of fluorescein localization in ren-
al tissue and 1251 localization determined by autora-
diography is illustrated in Fig. 5. Although silver
grains indicating 125J deposition appear in extra-
glomerular locations (Fig. SA), the predominant lo-
calization is intraglomerular and is congruent with
fluorescein deposition shown in Fig. SB. Tissue dis-
tortion and the haziness of the image in Fig. 5B are
attributable to the harshness of 3 weeks' exposure
in the dry photographic emulsion and to the devel-
oping solutions used for autoradiography. That both
fluorescein and 125j localize predominantly in
glomeruli is clear; this provides the basis for stating
that renal nondialyzable tissue-bound radioactivity
represents predominantly glomerular deposition of
AIgG.
Figure 6 shows a comparison of the quantity of
renal nondialyzable tissue-bound radioactivity for
normal mice, LCM mice, and LCM-P mice. Each
group of mice was approximately 5 months of age.
Determinations were performed 2 days after injec-
tion of the AIgG. Although there is overlap between
the three groups, only the average value for the
LCM-P animals is significantly different from that of
the normal animals. Even though these results dem-
onstrate increased renal accumulation of AIgG only
in LCM-P animals, studies of the amount of renal
material versus time were required to determine if
the increased renal accumulation resulted from a
decreased rate of renal clearance of AIgG. A com-
parison of the renal accumulation of aggregates
(± SEM) in normal and LCM-P mice is illustrated in
Fig. 7. It may be noted that at every time of exami-
nation more radioactivity was found in the LCM-P
animals than was found in normals. The pivotal ob-
servation in the figure is that the rate of clearance of
renal tissue-bound radioactivity is quite similar in
the LCM-P animals as compared to the normals.
This result indicates that the mesangial mechanism
for clearing AIgG is not impaired in spite of the re-
markable glomerular pathology characteristically
seen in LCM-P mice (Fig. 8).
The results of immunofluorescent microscopic
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evaluation of glomerular immune deposits in the
contralateral kidney from the same normal and
LCM-P mice used to prepare Fig. 7 are shown in
Table 1. The normal mice had only trace quantities
of mouse immunoglobulin and C3 detected by
rhodamine fluorescence in their glomeruli. Small
scattered mesangial deposits of green fluorescence
attributed to AIgG were noted, but at no time of
observation was an average grade greater than 0.8
found for the normal animals. The rhodamine fluo-
rescence from the mouse C3 stain (but not the
mouse Ig stain) was congruent with the fluorescein
immunofluorescence in normal mice, as shown in
Fig. 9. In contrast, LCM-P mice had heavy mesan-
gial deposits of mouse IgG and C3 which extended
into capillary loops (Fig. 10, A and B); the average
grade for all groups was 3.2 to 4.0. Glomerular de-
posits of fluorescein attributed to AIgG were most
extensive 1 day after injection of AIgG when the
average grade was 2.2; the normal and LCM-P mice
did not have discernibly different amounts of gb-
merular fluorescein after 3 days of observation. In
contrast to normal mice, LCM-P animals had gener-
ally more extensive glomerular accumulation of en-
dogenous murine Ig and C3 than they did of AIgG,
as shown in Fig. 10 where serial sections of a kidney
from an LCM-P mouse are shown. Apparently, cer-
tain areas of the glomeruli shown are closed to fur-
ther immune accumulation and the AIgG thus ex-
cluded (arrows, Fig. lOB compared to 1OD).
Table 2 shows the serum concentrations of TCA
precipitable radioactivity corresponding to the kid-
neys plotted in Fig. 7. It is noteworthy that the
LCM-P mice had higher serum concentrations of
protein-bound radioactivity than did the normals at
4 and 8 hours after injection.
Effect of injection of AIgG on serum parameters,
renal histology, and albuminuria. The AIgG used in
these studies has previously been shown to possess
properties of immune complexes [281, and we,
therefore, examined the injected mice for evidence
of detrimental effects from the AIgG. In normal
mice, abnormal albuminuria did not occur during 5
days of observation after the injection of AIgG.
Similarly, there was no increase in albumin excre-
tion in LCM-P animals following injection of AIgG.
Table 3 shows the serum parameters for normal,
LCM, and LCM-P mice examined 48 hours after in-
jection of 1 mg AIgG/g of body wt. The concentra-
tion of C3 was slightly lower in LCM and LCM-P
mice than it was in the normal animals. The values
shown are not different from the results obtained in
comparable groups of mice not injected with AIgG.
There was no effect of the injection of AIgG on the
BUN, hematocrit, or serum concentration of mouse
albumin. Finally, no light microscopic abnormal
histology attributable to the injection of A1gG was
noted. Based on these observations, AIgG injected
into mice had no demonstrable detrimental effect
when used in the quantities and by the route of ad-
ministration used in these studies.
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Fig. 7. Rate of removal of heat-aggregated human gamma
globulin from kidney versus time after injection of the aggre-
gates. Each point is the mean SEM for 5 normal or 5 LCM-P
mice.
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Fig. 6. Micrograms of heat-aggregated human gamma globulin
per single homogenized kidney after dialysis in normal and
virus-infected mice. Each point is the mean SEM for 5 mice.
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Fig. 8. Glomeruli from SWRIJ mice. All photomicrographs are shown at the same scale, original magnification x200. (a) Glomerulus
from a normal 6-month-old SWR/J mouse; (b) Glomerulus from an LCM nonproteinuric 6-month-old SWR/J mouse; (c, d) Glorneruli
from two dUferent LCM infected albuminuric S WRIJ mice. This figure demonstrates the marked increase in glomerular diameter as com-
pared to normal and nonalbuminuric LCM animals.
Measurement of blood clearance of AIgG: The
above data did not demonstrate an intrinsic gb-
merular defect in the clearance of AIgG accumu-
lated in the kidney although higher concentrations
of AIgG were present in the blood of the LCM-P
mice during the first day of observation. We, there-
fore, investigated the possibility that LCM virus
might induce a defect in the clearance of colloidal
material from the blood of virus-infected animals.
Conceptually, such a defect could lead to elevated
Table 1. Results of immunofluorescent microscopic evaluation of glomerular immune deposits in normal and LCM-infected albuminuric
mice after i.p. injection of aggregated human immunoglobulin (AIgG)'
Time after
Normal mice LCM albuminuric mice
Mouse Mouse Mouse Mouse
injection of AIgG IgG C3 AIgG IgG C3 AIgG
4hr Trace Trace 0.5 3.6 3.5 1.0
8hr Trace Trace 0.4 3.6 3.8 1.5
iday Trace Trace 0.8 3.5 3.6 2.2
2days Trace Trace 0.5 3.5 3.7 1.25
3 days Trace Trace 0.4 3.5 3.8 0.6
5 days Trace Trace 0.2 3.2 3.5 0.2
8 days Trace Trace 0.3 4.0 4.0 0.33
a See text of Methods section under Immunofluorescent studies and pathologic examination for explanation of the grading system
used
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concentrations of blood-borne colloid presented to
the glomerulus and resultant increased glomerular
uptake of such material to account for increased
glomerular accumulation. Each animal to be exam-
ined received an i.v. injection of 4 mg of AIgG per
25 g of body wt. The composite regression line ex-
pressed as change in percent of initial concentration
with time is shown in Fig. 11 for the first 17 such
mice studied. The correlation coefficient of each re-
gression line is 0.99. The mean t½ was 20.2 mm in
normal and 29.3 mm in LCM-infected animals (P <
0.005). Figure 12 shows the t1/2's for disappearance
of AIgG in an additional 18 normal, 27 LCM, and 13
LCM-P mice; though different preparations of AIgG
were used in these additional mice, the t1/2's for the
total group of normal (t'/2 = 22.3 [sEMI 1.3 mm)
as compared to LCM mice (t1/2 = 33.9 [SEMI 1.7
mm) or LCM-P mice (t1/2 = 37.3 [SEMI 2.7 mm)
were statistically different (P <0.001). The average
t½ for the LCM-P mice was slightly longer than was
the result for the LCM mice, although the result
was not statistically different.
Measurement of reticuloendothelialfunction with
colloidal carbon. In an effort to see if the slow blood
clearance of AIgG in LCM mice might be a more
generalized phenomenon, we performed studies us-
ing colloidal carbon (4 mg/25g of body wt) in 7 nor-
mal and 8 LCM mice. The log of the blood concen-
tration of colloidal carbon in micrograms/milliliter
was plotted against time after injection to obtain the
phagocytic index (k) and the t½ for blood clear-
ance. Figure 13 compares the composite regression
lines for normal and LCM mice expressed as
change in percent of initial concentration which was
the same in each group (800 jsg/ml of blood). The
slope of each plot represents the phagocytic index
(k); the correlation coefficient of each line was 0.99.
A comparison of individual half times of dis-
appearance (t½) for colloidal carbon in normal and
LCM-infected mice is presented in Fig. 12. The
mean t½ was 18.2 mm in normal and 21.5 mm in
LCM-infected mice (P <0.05), demonstrating a de-
creased phagocytic rate for injected carbon in
LCM-infected mice.
Pathologic observations of liver and spleen: Fig.
14 illustrates the histologic appearance of a section
of the spleen and liver from an SWR/J mouse 4
hours after injection of 4 mg of carbon or 4 mg of
AIgG per 25 g of body wt. The distribution of the
colloidal carbon in the hematoxylin-and-eosin-
stained light microscopic section is quite similar to
the distribution of AIgG shown in the immuno-
fluorescent micrograph. At the dose of carbon used,
Fig. 9. A section of renal tissue from a normal mouse injected
with 25 mg of AIgG 48 hours prior to the harvest of tissues: (A)
stained with a rhodamine-conjugated rabbit antimouse com-
plement antiserum and examined using a filter system excluding
green fluorescence,' (B) with the intrinsic green fluorescence of
the fluorescein-/aheled AIgG injected into the mouse. The red
fluorescence from the rhodamine conjugate was excluded by an
appropriate filter system. Note congruent deposition of mouse
complement and AIgG (original magnification, x200).
there was no carbon visible in the glomeruli. Simi-
larly, for a dose of 4 mg of AIgG per 25 g body wt,
there was only faint trace staining in glomeruli by
immunofluorescence. By 24 hours after injection,
the AIgG was no longer seen in the liver, and only
traces remained in the spleen. The findings in LCM
mice were similar.
Discussion
Conceptually, pathologic accumulation of materi-
al in glomeruli could result from either abnormal in-
creased glomerular uptake or decreased glomerular
clearance of the material. Logically, one factor in-
creasing glomerular uptake of colloid material is an
increased plasma colloid concentration, which in
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Fig. 10. Serial sectionsfrom an LCM-P mouse injected with 25 mg of AIgG 24 hourspriorto the harvest of tissues: (A) mouse immuno-
globulin deposition; (B) mouse ('3deposition; (C)LCM viralantigen.The black dots delineate Bowman's capsule for the four glomeruli.
Note the presence of LCM viral antigen in the tubules and also small glomerular deposits. (D) AIgG. Note that panels B and D have
remarkably similar morphology although the endogenous C3 seen in B is present in areas containing very little AlgG (original magnifica-
tion, x200).
turn may result from an impaired reticuloendotheli-
al clearance of blood-borne colloid. Our observa-
tions indicate that the rate of RES clearance of ex-
ogenous plasma colloid is decreased in both LCM
and LCM-P mice as compared to normal mice. At
any time after injection, this results in a higher
Table 2. Serum concentration of 21-labeled IgG in the blood of
mice following i.p. injection of 1 mg of AIgG per g of body weight
Time
hr
Normal mice
pg/in!
LCM-P mice5
pg/mi
I NDa 14±6
2 ND 55±4
4 40 69
8 13±4 21±3
24 5.5 0.5 6.5 0.7
a Not determined because >40% AIgG remained in peritoneal
cavity.
Each value represents an average of 5 determinations SEM.
plasma concentration of injected colloid in LCM
(Figs. 11 and 12) or LCM-P mice (Fig. 12 and Table
2) as compared to normal mice. Net renal accumu-
lation of AIgG was increased only in LCM-P mice
(Fig. 6) although the rate of renal clearance of AIgG
in these animals was the same as it was in normal
mice (Fig. 7), indicating that a decreased rate of
mesangial clearing was not responsible for the ab-
normal glomerular accumulation of AIgG in LCM-P
mice.
The reason for abnormal glomerular accumula-
tion of AIgG in LCM-P mice as opposed to LCM
mice is not discernible from these studies, although
two conceptual possibilities may be considered.
First, increased glomerular AIgG accumulation
might result from abnormalities in the quantity of
AIgG delivered to the glomerulus. If this were the
case, the methods used in these experiments were
unable to detect a difference between LCM and
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Table 3. Blood parametersa
Normal(N10) LCM-non(N albuminuric=I1) LCM-albUminunc(N=10)
Serum albumin, mg/mi 48 3 40 3' 40 4b
Serum immunoglobulin,mg/mi 2.3 0.2 3•5 0•5b 5.0 0.6"
Serum C-3, % ofnormal 110 6 98 8 62 6"
BUN,mg/lOOmi 18 16 18
Hematocrit, % 42 1 41 1 36 2"
a All results expressed as mean SEM.
b p < 0.05, different than for normal mice (Student's unpaired t test).
LCM-P mice (Fig. 12); the observed intragroup var-
iability in the measured t½ for blood clearance of
AIgG indicates that subtle but possibly important
differences in the blood levels of AIgG may not
have been detected by the methodology used. The
second conceptual possibility is that RES function
is similarly slowed in LCM and LCM-P mice; in this
case, the increased glomerular accumulation of
AIgG seen in LCM-P mice would have to be ex-
plained either by qualitative differences in the
phlogogenicity of endogenous blood-borne material
or other primary mechanisms, unknown, which re-
suit in more severe glomerular pathology in LCM-P
mice. Although giomerular volume has not been
quantitatively correlated with an expanded mesan-
gium available for AIgG accumulation, the in-
creased glomerular volume in LCM-P mice (Fig. 8
and Ref. 27) provides a possible explanation for the
increased glomerular accumulation of AIgG in
LCM-P mice.
Regardless of the reasons for increased renal ac-
cumulation of AIgG in LCM-P mice, our results in-
dicate that there is no functional impairment of the
glomerular clearing (mesangial) system in this ani-
mal model of spontaneously occurring immune
complex glomerulonephritis. In this report, we
adapted the techniques of Mauer et al [29] to eval-
uate mesangial function in individual mice. Immu-
nofluorescent and autoradiographic examination of
kidney sections from mice that had been injected
with fluoresceinated AIgG showed that the aggre-
gates were deposited predominantly in glomeruli.
The kidney is the major organ of excretion for ra-
dioactive iodine released by the metabolism of la-
beled AIgG; it was found, however, that 99% of the
urinary radioactivity was dialyzable. Thus, it has
been concluded that the residual radioactivity re-
maining in the homogenized kidney sediment after
dialysis and centrifugation represents predominant-
ly glomerular-bound AIgG. Additional control ex-
periments indicate that very little added free 125J or
1251-IgG adhere to a tissue homogenate following
dialysis and centrifugation. Intraperitoneal injection
of deaggregated fluorescein-labeled 1251-IgG result-
ed in no discernible glomerular or renal fluores-
cence at any time after injection; thus, glomerular
fluorescence observed in these experiments may be
attributed to AIgG accumulation. Finally, although
measurable quantities of deaggregated 25J-IgG lo-
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Fig. 11. Comparison of the rate of clearance of AIgG from the
blood of normal and LCM mice. The phagocytic index is denoted
by k.
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Fig. 13. Comparison of the rate of clearance of colloidal carbon
from the blood of normal and LCM mice.
calized in renal tissue following i.p. injection, there
was no difference in the amounts present in normal
as compared to LCM animals. Thus, we believe
that the excess radioactivity observed in tissue ho-
mogenates from LCM-P mice reflects predominant-
ly differences in glomerular accumulation of AIgG.
The inflammatory properties of the AIgG used in
these studies were examined in detail. Serum com-
plement levels, white blood cell counts, and serum
immunoglobulin concentrations in mice were deter-
mined after injection of AIgG; the values were com-
parable in control and injected groups. Histologic
appearance of tissues from mice receiving AIgG
was not distinguishable from that of mice which had
not received AIgG. Specifically, the AIgG did not
induce detectable glomerular pathology. The AIgG
did not induce albuminuria in normal animals and
did not alter albuminuria in LCM-P animals. These
results indicate that AIgG may serve as an in-
nocuous immune complex-like material in the stud-
ies described here.
The results of these studies of immune complex
glomerulonephritis are in remarkable agreement
with similar studies in rabbits injected with bovine
serum albumin [36, 37]. From Fig. 5 it may be noted
that the average maximum amount of AIgG present
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Fig. 14. Photomicrographs (magnjfication, xlOO) of the distribution of colloidal carbon and AIgG in liver and spleen, showing local-
ization of (A) carbon in the Kupffer cells of liver, (B) carbon in parafollicular macrophages of spleen, (C) AIgG in the Kupffer cells of
liver, and (D) of AIgG in parafollicular macrophages of the spleen. Notice that the distribution of carbon and AIgG is almost identical.
in one LCM-P kidney was 70 tg. By extrapolating
this value to two kidneys and expressing the results
as a percent of total injected dose of AIgG, it may
be calculated that only 0.5% of the injected AIgG
accumulates in the kidney. This is numerically iden-
tical to the results reported by Wilson and Dixon
[36] for glomerulonephritic rabbits after injection of
bovine serum albumin. In addition, Wilson and Dix-
on noted that depression of RES function was fol-
lowed quickly by the onset of albuminuria in these
rabbits [361. Others 138] have demonstrated that
very little glomerular accumulation of immune com-
plexes occurs in the absence of saturation of the
RES. As in the present study, others have found
that the glomerular mesangial clearance mechanism
is normal in a variety of experimental models, in-
cluding aminonucleoside nephrosis [29], antiglo-
merular basement membrane nephritis [35], and
serum sickness nephritis in rabbits [39].
These results in a spontaneously occurring model
of ICGN, as well as the increased glomerular pa-
thology observed in several studies of RES block-
ade [40—42], are consistent with the hypothesis that
impaired RES function is one more factor to consid-
er in the pathogenesis of ICGN. Although the nature
of the RES alteration remains to be elucidated,
the pathogenesis of the impaired RES clearance
of an injected exogenous colloid might be second-
ary to a total decreased phagocytic capacity or al-
ternatively to competitive inhibition of the RES by
an endogenous colloid. Results from several studies
support the concept of impaired RES function being
a factor in ICGN. Evaluation of phagocytic activity
of the RES in several inbred strains of mice have
shown a significant depression of measured phago-
cytic activity in those strains most susceptible to
immune complex disease [43], and, in fact, the low-
est function was found in SWRIJ mice which devel-
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op quite severe immune complex glomerulonephri-
tis in response to chronic LCM virus infection.
Ford has shown that glomerular deposition of ag-
gregated bovine serum albumin is inversely propor-
tional to RES function and that blockade or stimula-
tion of the RES affects glomerular deposition of ag-
gregates [441. The observations that acute LCM
virus infection [45] or acute infections with other
viruses [46, 47] result in impaired host phagocytic
activity are difficult to compare with the present ob-
servations obtained in chronically infected mice;
the results regarding inadequate RES function re-
ported in those studies, however, tend to agree with
observations obtained in the present study.
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